Latest News | Lupin Gets USFDA Nod for Generic Medication
Get latest articles and stories on Latest News at LatestLY. Drug maker Lupin on Friday said it has received approval from the US health regulator to market a generic medication to treat bladder problems.
New Delhi, Jan 6 (PTI) Drug maker Lupin on Friday said it has received approval from the US health regulator to market a generic medication to treat bladder problems.
The company has received approval from the US Food and Drug Administration to market Fesoterodine Fumarate extended-release tablets in strengths of 4 mg and 8 mg, the Mumbai-based drug maker said in a regulatory filing.
Also Read | Avatar The Way of Water Surpasses Top Gun Maverick at Global Box Office With a Total of $1.51 Billion.
The company's product is the generic equivalent of Pfizer's Toviaz extended-release tablets, it added.
As per IQVIA data, Fesoterodine Fumarate extended-release tablets (4 mg and 8 mg) had estimated annual sales of USD 177 million in the US.
Also Read | Jay B Birthday: Five Random Videos Of The GOT7 Member We Crush On Everyday.
(The above story is verified and authored by Press Trust of India (PTI) staff. PTI, India’s premier news agency, employs more than 400 journalists and 500 stringers to cover almost every district and small town in India.. The views appearing in the above post do not reflect the opinions of LatestLY)